Pavan Atluri


Affiliation: University of Pennsylvania
Country: USA


  1. Chen C, Auvil B, Zhang J, Chung J, Gaffey A, Bermudez C, et al. Transplant Volume Is Associated With Graft Acceptance Threshold and Center Resource Availability. J Card Fail. 2019;: pubmed publisher
    ..053). Transplants for candidates with high sequence numbers and unrestricted operating room availability are associated with increased center volume without sacrificing post-transplantation survival. ..
  2. Gaffey A, Chen M, Trubelja A, Venkataraman C, Chen C, Chung J, et al. Delivery of progenitor cells with injectable shear-thinning hydrogel maintains geometry and normalizes strain to stabilize cardiac function after ischemia. J Thorac Cardiovasc Surg. 2019;157:1479-1490 pubmed publisher
    ..The cellular construct provides a normalization of strain measurements and reduces left ventricular dilatation, thus resulting in improvement of left ventricular function. ..
  3. Pietras C, Atluri P. Surgical Implantation of Intracorporeal Devices: Perspective and Techniques. Cardiol Clin. 2018;36:465-472 pubmed publisher
    ..With the advancement of technology, surgical implant strategy continues to evolve, incorporating less-invasive approaches into the armamentarium of the experienced surgeon. ..
  4. Chung J, Stetson R, Gordon J, Chen C, Gaffey A, Rame J, et al. Better With Time: An Economic Assessment of Long-Term Mechanical Circulatory Support in a Population Surviving at Least 1 Year with a Left Ventricular Assist Device. Semin Thorac Cardiovasc Surg. 2018;: pubmed publisher
  5. Daniel M, Chen C, Chung J, Goldberg L, Acker M, Atluri P. Interaction of Donor and Recipient Age: Do Older Heart Transplant Recipients Require Younger Hearts?. Ann Thorac Surg. 2019;107:62-66 pubmed publisher
    ..With careful allograft selection, use of donor hearts to age 50 may be acceptable among older transplant recipients. ..
  6. Gaffey A, Phillips E, Howard J, HUNG G, Han J, Emery R, et al. Prior Sternotomy and Ventricular Assist Device Implantation Do Not Adversely Impact Survival or Allograft Function After Heart Transplantation. Ann Thorac Surg. 2015;100:542-9 pubmed publisher
    ..The decision to manage a patient medically while awaiting transplantation versus an LVAD bridge strategy should not be limited by concerns of subsequent poor outcomes after transplantation. ..
  7. Gaffey A, Chen M, Venkataraman C, Trubelja A, Rodell C, Dinh P, et al. Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium. J Thorac Cardiovasc Surg. 2015;150:1268-76 pubmed publisher
    ..A novel injectable shear-thinning HA hydrogel seeded with EPCs enhanced cell retention and vasculogenesis after delivery to ischemic myocardium. This therapy limited adverse myocardial remodeling while preserving contractility. ..
  8. Atluri P, Stetson R, HUNG G, Gaffey A, Szeto W, Acker M, et al. Minimally invasive mitral valve surgery is associated with equivalent cost and shorter hospital stay when compared with traditional sternotomy. J Thorac Cardiovasc Surg. 2016;151:385-8 pubmed publisher
    ..There is greater operative cost associated with minimally invasive mitral valve surgery that is offset by shorter intensive care unit and hospital stays. ..
  9. Kilic A, Chen C, Gaffey A, Wald J, Acker M, Atluri P. Preoperative renal dysfunction does not affect outcomes of left ventricular assist device implantation. J Thorac Cardiovasc Surg. 2018;156:1093-1101.e1 pubmed publisher
    ..Renal dysfunction alone should not serve as an absolute contraindication to LVAD therapy. ..

More Information


  1. Gaffey A, Cucchiara A, Goldberg L, Blumberg E, Acker M, Atluri P. Transplantation of Center for Disease Control "High-Risk" Donor Hearts Does Not Adversely Impact Long-Term Outcomes in Adults. J Card Fail. 2016;22:376-82 pubmed publisher
    ..7571). HRD status does not significantly affect recipient outcomes after OHT. Increased use of HRD grafts could augment donor pool and decrease the mortality associated with long waitlist times. ..
  2. Gaffey A, Doll S, Thomasson A, Venkataraman C, Chen C, Goldberg L, et al. Transplantation of "high-risk" donor hearts: Implications for infection. J Thorac Cardiovasc Surg. 2016;152:213-20 pubmed publisher
    ..Furthermore, the risk of transmission of infection from donors in this subgroup seems to be minimal. ..
  3. Chen C, Sprys M, Gaffey A, Chung J, Margulies K, Acker M, et al. Low ejection fraction in donor hearts is not directly associated with increased recipient mortality. J Heart Lung Transplant. 2017;36:611-615 pubmed publisher
    ..106). Recipients of hearts with reduced EF have equivalent 1-year survival compared with recipients of hearts with normal EF. Donor hearts with reduced EF show significant functional recovery after transplant. ..
  4. Gaffey A, Chen C, Chung J, Han J, Owens A, Acker M, et al. Extended distance cardiac allograft can successfully be utilized without impacting long-term survival. J Heart Lung Transplant. 2017;36:968-972 pubmed publisher
    ..Donor heart procurement from increased distance may not directly increase morbidity and mortality post-heart transplant. ..
  5. Gaffey A, Chen C, Chung J, Phillips E, Wald J, Williams M, et al. Improved Approach With Subcostal Exchange of the HeartMate II Left Ventricular Assist Device: Difference in On and Off Pump?. Ann Thorac Surg. 2017;104:1540-1546 pubmed publisher
    ..The subcostal approach can be performed safely both on and off cardiopulmonary bypass. ..